| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.8M | — |
| Cost of Revenue | $4.0M | — |
| R&D Expense | $1.2M | +4.1% |
| SG&A Expense | $42.5M | +564.2% |
| Operating Income | -$32.4M | -328.3% |
| Pre-tax Income | -$50.7M | -537.4% |
| Income Tax | -$7.4M | — |
| Net Income | -$43.3M | -444.5% |
| EPS (Basic) | -$23.04 | -1511.2% |
| EPS (Diluted) | -$23.04 | -1511.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.0M | +3403.5% |
| Accounts Receivable | $8.9M | — |
| Inventory | $23.6M | — |
| Current Assets | $53.4M | +3801.0% |
| Total Assets | $130.4M | +9424.0% |
| Current Liabilities | $26.0M | +536.6% |
| Total Liabilities | $91.5M | +2141.3% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.6M | -290.0% |
| Capital Expenditures | $99K | — |
| Investing Cash Flow | -$5.2M | — |
| Financing Cash Flow | $45.3M | +630.1% |
| Free Cash Flow | -$22.7M | -291.7% |
| $38.9M |
| +1532.6% |